Camlin Fine Sciences Ltd
₹ 130
7.10%
27 May
- close price
About
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
Key Points
- Market Cap ₹ 2,501 Cr.
- Current Price ₹ 130
- High / Low ₹ 335 / 96.2
- Stock P/E 204
- Book Value ₹ 54.2
- Dividend Yield 0.00 %
- ROCE 4.05 %
- ROE 1.26 %
- Face Value ₹ 1.00
Pros
- Company's working capital requirements have reduced from 36.4 days to 23.0 days
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.74% over past five years.
- Company has a low return on equity of -7.88% over last 3 years.
- Earnings include an other income of Rs.60.1 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE Commodities BSE 1000
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 558 | 489 | 534 | 721 | 892 | 1,049 | 1,187 | 1,412 | 1,682 | 1,454 | 1,667 | 1,723 | |
| 474 | 397 | 502 | 705 | 819 | 914 | 1,000 | 1,254 | 1,471 | 1,284 | 1,447 | 1,616 | |
| Operating Profit | 84 | 92 | 32 | 16 | 73 | 135 | 187 | 158 | 211 | 170 | 220 | 107 |
| OPM % | 15% | 19% | 6% | 2% | 8% | 13% | 16% | 11% | 13% | 12% | 13% | 6% |
| 9 | -1 | 14 | 12 | 14 | 3 | 5 | 33 | -4 | -142 | -203 | 60 | |
| Interest | 24 | 24 | 31 | 32 | 41 | 48 | 42 | 41 | 64 | 70 | 111 | 73 |
| Depreciation | 16 | 17 | 22 | 27 | 29 | 33 | 44 | 56 | 63 | 56 | 64 | 71 |
| Profit before tax | 53 | 50 | -6 | -31 | 17 | 58 | 105 | 94 | 80 | -99 | -158 | 23 |
| Tax % | -4% | 28% | -26% | -22% | 82% | 49% | 38% | 36% | 50% | 6% | 0% | -2% |
| 55 | 36 | -4 | -24 | 3 | 30 | 65 | 60 | 40 | -105 | -158 | 24 | |
| EPS in Rs | 5.11 | 3.30 | -0.96 | -2.18 | 0.04 | 2.23 | 3.56 | 3.45 | 2.96 | -4.94 | -7.40 | 1.44 |
| Dividend Payout % | 8% | 12% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 8% |
| 3 Years: | 1% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | -25% |
| 3 Years: | -40% |
| TTM: | 109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -6% |
| 3 Years: | -8% |
| 1 Year: | -48% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -2% |
| 3 Years: | -8% |
| Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 12 | 12 | 12 | 13 | 16 | 16 | 17 | 19 | 19 |
| Reserves | 125 | 167 | 202 | 359 | 359 | 391 | 631 | 732 | 804 | 848 | 883 | 1,022 |
| 160 | 180 | 331 | 373 | 461 | 539 | 550 | 646 | 801 | 683 | 681 | 720 | |
| 131 | 123 | 126 | 273 | 255 | 290 | 282 | 396 | 425 | 424 | 454 | 563 | |
| Total Liabilities | 426 | 479 | 669 | 1,016 | 1,087 | 1,232 | 1,475 | 1,790 | 2,045 | 1,972 | 2,037 | 2,324 |
| 106 | 140 | 201 | 278 | 272 | 306 | 584 | 601 | 858 | 816 | 704 | 887 | |
| CWIP | 3 | 25 | 8 | 14 | 59 | 179 | 24 | 215 | 43 | 46 | 10 | 33 |
| Investments | 1 | 1 | 19 | 115 | 11 | 7 | 7 | 7 | 8 | 8 | 61 | 30 |
| 316 | 313 | 442 | 609 | 745 | 740 | 861 | 966 | 1,136 | 1,102 | 1,262 | 1,373 | |
| Total Assets | 426 | 479 | 669 | 1,016 | 1,087 | 1,232 | 1,475 | 1,790 | 2,045 | 1,972 | 2,037 | 2,324 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46 | 72 | -9 | -15 | -9 | 86 | 117 | 145 | 51 | 139 | 27 | ||
| -26 | -66 | -70 | -149 | -2 | -90 | -133 | -249 | -125 | -66 | -75 | ||
| -15 | -7 | 91 | 182 | 26 | 3 | 39 | 136 | 60 | -86 | 72 | ||
| Net Cash Flow | 4 | -1 | 13 | 18 | 15 | -1 | 23 | 32 | -14 | -13 | 24 | |
| Free Cash Flow | 19 | 5 | -39 | -34 | -78 | -48 | 34 | -68 | -93 | 79 | -16 | |
| CFO/OP | 68% | 91% | 5% | -33% | 10% | 77% | 82% | 111% | 34% | 110% | 30% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 56 | 99 | 104 | 86 | 88 | 83 | 77 | 66 | 72 | 72 | 79 |
| Inventory Days | 184 | 311 | 277 | 207 | 219 | 204 | 200 | 178 | 255 | 256 | 233 | 199 |
| Days Payable | 144 | 171 | 110 | 154 | 127 | 119 | 99 | 112 | 129 | 154 | 162 | 200 |
| Cash Conversion Cycle | 114 | 196 | 266 | 157 | 178 | 173 | 184 | 143 | 192 | 174 | 143 | 78 |
| Working Capital Days | 12 | 1 | -6 | 19 | 43 | 22 | 55 | 40 | 42 | 51 | 35 | 23 |
| ROCE % | 28% | 24% | 5% | 0% | 7% | 11% | 13% | 10% | 10% | 8% | 11% | 4% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Consolidated Installed Capacity MTPA |
|
||||||||||
| Number of Employees (Direct) Number ・Includes some standalone data |
|||||||||||
| Production Volume - CFS Europe (Diphenol Plant) MT ・Standalone data |
|||||||||||
| Production Volume - Standalone (Tarapur & Dombivli) MT ・Standalone data |
|||||||||||
| Global Presence (Number of Countries) Countries |
|||||||||||
| Global Market Share - TBHQ & BHA % |
|||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
|||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
8h - Camlin Fine Sciences submitted its Annual Secretarial Compliance Report for year ended March 31, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Newspaper Publication - Audited Financial Results for the quarter and year ended 31.03.2026
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Audio recording of May 26, 2026 conference call on audited FY26 results available on company website.
-
Announcement under Regulation 30 (LODR)-Change in Management
2d - Board approved FY26 audited results, AGM on August 11, 2026, and CFO appointment effective August 18, 2026.
-
Board Meeting Outcome for Outcome Of Board Meeting
2d - Board approved FY26 audited results, AGM on Aug 11, 2026, and appointed Pankaj Pandey CFO from Aug 18.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Feb 2022TranscriptAI SummaryPPT
-
Jan 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
-
May 2021TranscriptAI SummaryPPT
-
May 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Aug 2020TranscriptAI SummaryPPT
-
Jun 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Dec 2019TranscriptAI SummaryPPT
-
Dec 2019TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
May 2016TranscriptAI SummaryPPT
Business Verticals